Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 1/9/12 → 5/1/13 |
Funding
- Chiltern International, Inc. (Prot #SP902 // Prot #SP902)
- UCB Biosciences, Inc. (Prot #SP902 // Prot #SP902)
Prot #SP902: A Historical-controlled, Multicenter, Double-blind, Randomized Trial to Assess the Efficacy and Safety of Conversion to Lacosamide 400mg/day Monotherapy in Subjects with Partial-onset Seizures
- Macken, Micheal P (PD/PI)
- Gerard, Elizabeth Erway (Co-Investigator)
- Schuele, Stephan U (Co-Investigator)
Project: Research project